Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

FDA restricts J&J’s COVID-19 vaccine on blood clot risks

The Food and Drug Administration is limiting the use of the J&J shot, which received U.S. clearance in February 2021. In a statement released on...

FDA refuses to approve China-tested cancer drugs, shares fall

The U.S. Food & Drug Administration declined to approve two China-tested cancer treatments on Monday, raising concerns over the future of drugs tested in...

FDA approves Sol-Gel’s drug for treatment of inflammatory lesions of rosacea

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), announced the Food and Drug Administration (FDA) approval of its drug product, EPSOLAY®, a proprietary cream formulation of benzoyl...

FDA rejects Ampio’s proposed changes to a phase III study of a pain medication for osteoarthritis

Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee...

FDA postpones approval of Teva’s schizophrenia drug

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration (“FDA”) has issued a...

FDA grants Regenerative Medicine Advanced Therapy designation to Direct Biologics’ extracellular vesicle drug for Covid-19

Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration has...
spot_img

Expert Articles

spot_img